Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WINSTOCK, Adam R")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 15 of 15

  • Page / 1
Export

Selection :

  • and

Controlling new drugs under marketing regulationsHUGHES, Brendan; WINSTOCK, Adam R.Addiction (Abingdon. Print). 2012, Vol 107, Num 11, pp 1894-1899, issn 0965-2140, 6 p.Article

Ketamine : From medicine to misuseWOLFF, Kim; WINSTOCK, Adam R.CNS drugs. 2006, Vol 20, Num 3, pp 199-218, issn 1172-7047, 20 p.Article

National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in AustraliaWINSTOCK, Adam R; ANDERSON, Caroline M; SHERIDAN, Janie et al.Medical journal of Australia. 2006, Vol 184, Num 11, pp 560-562, issn 0025-729X, 3 p.Article

Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, AustraliaWINSTOCK, Adam R; LEA, Toby; SHERIDAN, Janie et al.Addiction (Abingdon. Print). 2010, Vol 105, Num 2, pp 335-342, issn 0965-2140, 8 p.Article

What Is Diversion of Supervised Buprenorphine and How Common Is It?WINSTOCK, Adam R; LEA, Toby; SHERIDAN, Janie et al.Journal of addictive diseases. 2009, Vol 28, Num 3, pp 269-278, issn 1055-0887, 10 p.Article

Methods and Motivations for Buprenorphine Diversion from Public Opioid Substitution Treatment ClinicsWINSTOCK, Adam R; LEA, Toby; JACKSON, Anthony P et al.Journal of addictive diseases. 2009, Vol 28, Num 1, pp 57-63, issn 1055-0887, 7 p.Article

Ecstasy pill testing : harm minimization gone too far?WINSTOCK, Adam R; WOLFF, Kim; RAMSEY, John et al.Addiction (Abingdon. Print). 2001, Vol 96, Num 8, pp 1139-1148, issn 0965-2140Article

Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sampleWINSTOCK, Adam R; KAAR, Stephen; BORSCHMANN, Rohan et al.Journal of psychopharmacology (Oxford). 2014, Vol 28, Num 1, pp 49-54, issn 0269-8811, 6 p.Article

Assessment and management of . cannabis use disorders in primary careWINSTOCK, Adam R; FORD, Chris; WITTON, John et al.BMJ. British medical journal (International ed.). 2010, Vol 340, Num 7750, pp 800-804, issn 0959-8146, 5 p.Article

4-MTA: a new synthetic drug on the dance sceneWINSTOCK, Adam R; WOLFF, Kim; RAMSEY, John et al.Drug and alcohol dependence. 2002, Vol 67, Num 2, pp 111-115, issn 0376-8716Article

Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United StatesBARRATT, Monica J; FERRIS, Jason A; WINSTOCK, Adam R et al.Addiction (Abingdon. Print). 2014, Vol 109, Num 5, pp 774-783, issn 0965-2140, 10 p.Article

Mephedrone, new kid for the chop?WINSTOCK, Adam R; MITCHESON, Luke R; DELUCA, Paolo et al.Addiction (Abingdon. Print). 2011, Vol 106, Num 1, pp 154-161, issn 0965-2140, 8 p.Article

The prevalence and natural history of urinary symptoms among recreational ketamine usersWINSTOCK, Adam R; MITCHESON, Luke; GILLATT, David A et al.BJU international (Papier). 2012, Vol 110, Num 11, pp 1762-1766, issn 1464-4096, 5 p.Article

Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation : Pandemic (H1N1) 2009DEGENHARDT, Louisa; LARANCE, Briony K; BELL, James R et al.Medical journal of Australia. 2009, Vol 191, Num 3, pp 161-165, issn 0025-729X, 5 p.Article

High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: Neural consequences and comparison with methamphetamineMOTBEY, Craig P; CLEMENS, Kelly J; McGREGOR, Lain S et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 9, pp 823-836, issn 0269-8811, 14 p.Article

  • Page / 1